Navigation Links
Thomas P. Rice Elected to Board of Directors of Par Pharmaceutical Companies, Inc.
Date:6/12/2009

WOODCLIFF LAKE, N.J., June 12 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that Thomas P. Rice has been elected to the company's board of directors. Mr. Rice was also appointed to the Audit Committee and the Nominating-Corporate Governance Committee.

Currently, Mr. Rice is a principal and co-founder of Columbia Investments LLC, Baltimore, Maryland, which invests in local businesses in Maryland. From February 2004 to November 2006, he was the Chief Executive Officer of Andrx Corporation when Andrx was sold to Watson Pharmaceuticals. He was also a director of Andrx from April 2003 until November 2006. Mr. Rice is currently a director of Chemed Corporation, the owner of two wholly-owned subsidiaries: VITAS Healthcare Corporation and Roto-Rooter. Mr. Rice has an M.S. in Finance from Loyola College and a B.S. from the University of Maryland. He is also a Certified Public Accountant.

Patrick G. LePore, Par's Chairman, President and Chief Executive Officer, said, "We are very pleased to welcome Tom to our board of directors. Tom is a proven and successful executive whose extensive knowledge of generic and branded pharmaceutical operations will bring valuable insight to our board."

About Par

Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit www.parpharm.com.


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Thomas R. Frieden, M.D., M.P.H., Begins Role as CDC Director and ATSDR Administrator
2. Go Healthy Receives Letter of Endorsement from the Texas Chiropractic Association, District Five State Director - Dr. Thomas Klesmit
3. ASPH Supports President Obamas Selection of New York City Health Commissioner Thomas R. Frieden, MD, MPH, for CDC Director
4. Statement from CCF Against CDC Nominee Thomas Frieden
5. Trust for Americas Health Supports Appointment of Thomas Frieden to Lead CDC
6. Michael DeMane Joins Thomas, McNerney & Partners as Senior Advisor
7. Nashville's eDoc4u Signs Partnership Agreement With Saint Thomas Health Services
8. Availity Promotes Russ Thomas to President and Chief Operating Officer
9. Guy's and St Thomas' NHS Foundation Trust extends patient care benefits of BigHand Digital Dictation
10. Thomas C. Barber, MD, Elected Chair of Academy Board of Councilors
11. SCANs Thomas Lescault Elected President of New Arizona Association of Health Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... The OSHA Training Center at ... Center headquartered in Northern California, has issued an important reminder to employers to ... Employers with workers exposed to high temperatures should establish a complete heat ...
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: